OVERVIEW

44th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID) is organized by Kenes Group, European Society for Paediatric Infectious Diseases (ESPID) and will be held from Jun 01 - 05, 2026 at Bologna Congress Center, Bologna, Emilia-Romagna, Italy.

Description:
ESPID 2026 Will Bring Together Our Global Community at a Pivotal Moment for Child Health and Infectious Diseases. This Year’s Meeting Will Focus on a Topic of Growing Urgency: Climate Change and Emerging Infectious Diseases. There Will Explore How Environmental Shifts Are Shaping the Epidemiology of Infections, Challenging Our Clinical Practices, and Calling for Innovative Responses in Research, Prevention, and Care.

Why Attend?
Latest PID Research & Results
ESPID is a gathering of PID researchers, clinicians and practicioners coming together to share their latest results, debate on polarizing topics in the field and drive change forward. We are all working towards a healthier future for children by contributing with our perspectives.

Meet the Experts
Join expert-led lectures, workshops, debates, and masterclasses on the latest advancements in the field. This is your opportunity to learn from the best researchers and clinicians from all over the world!

Connect & Network
Expand your professional network within a vibrant community of paediatric infectious disease specialists from across the globe. ESPID creates the perfect environment for meaningful connections that extend far beyond the conference halls

Advance your Career
ESPID 2026 is the perfect platform to present your research and cases to leading PID specialists. Connect with influential researchers, establish your expertise among peers, and forge partnerships that will transform your practice and propel your research forward.

Make a Difference
ESPID is making a difference that extends far beyond our conferences. Through groundbreaking research that advances child health outcomes, sustainable initiatives to improve our footprint each year, and dedicated donation efforts that reach those most in need, we’re creating lasting impact in paediatric infectious diseases worldwide.